Jagiellonian University Repository

The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines

pcg.skipToMenu

The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines

Show full item record

dc.contributor.author Ciołczyk-Wierzbicka, Dorota [SAP20001784] pl
dc.contributor.author Gil, Dorota [SAP20002112] pl
dc.contributor.author Laidler, Piotr [SAP20000499] pl
dc.date.accessioned 2020-04-15T10:33:07Z
dc.date.available 2020-04-15T10:33:07Z
dc.date.issued 2012 pl
dc.identifier.issn 0929-8673 pl
dc.identifier.uri https://ruj.uj.edu.pl/xmlui/handle/item/153856
dc.language eng pl
dc.rights Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa *
dc.rights.uri http://creativecommons.org/licenses/by/4.0/pl/legalcode *
dc.title The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines pl
dc.type JournalArticle pl
dc.description.physical 145-151 pl
dc.abstract.en Malignant melanoma is a disease with high mortality rate caused by rapid metastasis. Cell motility is physically and biochemically restricted by cadherin-mediated cell interactions and signalling pathways, and alterations in cadherin expression strongly correlate with E to N-cadherin switch as well as the metastasis and progression of tumours. Contrary to E-cadherin, N-cadherin plays an important role in stimulating processes of cell division, migration, differentiation and death. In this study we investigated the role of N-cadherin in proliferation and AKT, ERK, beta-catenin signalling pathway in human melanoma cells: WM793(VGP), WM115(VGP) from the primary tumor site, as well as Lu1205(lung) and WM266-4(skin) from metastatic sites. N-cadherin, pAKT(S473), β-catenin, pERK1/2(T202/Y204), cyclin D1, cyclin D3, cyclin-dependent kinases CDK4, CDK6, and p15, p16, p21, p27 inhibitors expression was determined by western blot analysis. The study on proliferation of cells was performed with the use of BrdU incorporation and crystal violet staining assays. Knock-out of N-cadherin gene expression by siRNA process reduced the expression of: pAKT(S473), pERK1/2(T202/Y204), betacatenin, cyclin D1, cyclin D3 , cyclin-dependent kinases CDK4, CDK6 while increasing expression of cell cycle inhibitors p21 and p27, and significantly decreased cell proliferation (50-70%). The collected data indicate that N-cadherin mediates the effect of cell cycle in G1 phase by AKT, β-catenin, and ERK signalling pathway. These results suggest that increased expression of N-cadherin significantly contributes to the increased invasive potential of melanoma cells. Silencing of N-cadherin arrests cell growth at G1 phase and inhibits the entry into S-phase which is of great importance as to its possible future use in cancer treatment. pl
dc.subject.en AKT pl
dc.subject.en β-catenin pl
dc.subject.en cell cycle pl
dc.subject.en ERK pl
dc.subject.en melanoma pl
dc.subject.en N-cadherin pl
dc.subject.en proliferation pl
dc.subject.en siRNA pl
dc.subject.en Malignant melanoma pl
dc.subject.en tumours pl
dc.description.volume 19 pl
dc.description.number 1 pl
dc.identifier.doi 10.2174/092986712803414006 pl
dc.identifier.eissn 1875-533X pl
dc.title.journal Current Medicinal Chemistry pl
dc.language.container eng pl
dc.affiliation Wydział Lekarski : Zakład Chemii Fizjologicznej pl
dc.subtype Article pl
dc.rights.original CC-BY; inne; ostateczna wersja wydawcy; w momencie opublikowania; 0 pl
dc.identifier.project ROD UJ / OP pl
.pointsMNiSW [2012 A]: 40


Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa